Birdwatch Note
2024-12-04 18:26:49 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Covid, or SARS2, is still a threat to everyone. New study shows that SARS-CoV-2 spike protein accumulates & persists in the body for years after infection, especially in the skull-meninges-brain axis, potentially driving long COVID. mRNA vaccines help but cannot stop it. https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(24)00438-4
Written by 43A4988A512788EC863E471B327C27D17CEB1F79A3CD067C2E491151A58F4863
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1863749127550513167
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1864375825396560095
- noteId - 1864375825396560095
- participantId -
- noteAuthorParticipantId - 43A4988A512788EC863E471B327C27D17CEB1F79A3CD067C2E491151A58F4863
- createdAtMillis - 1733336809860
- tweetId - 1863749127550513167
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Covid, or SARS2, is still a threat to everyone. New study shows that SARS-CoV-2 spike protein accumulates & persists in the body for years after infection, especially in the skull-meninges-brain axis, potentially driving long COVID. mRNA vaccines help but cannot stop it. https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(24)00438-4
Note Ratings
| rated at | rated by | |
| 2024-12-04 18:19:08 -0600 | Rating Details | |
| 2024-12-04 17:47:54 -0600 | Rating Details | |
| 2024-12-04 17:29:06 -0600 | Rating Details | |
| 2024-12-04 17:15:12 -0600 | Rating Details | |
| 2024-12-04 17:15:09 -0600 | Rating Details | |
| 2024-12-04 17:00:32 -0600 | Rating Details | |
| 2024-12-04 17:00:12 -0600 | Rating Details | |
| 2024-12-04 16:56:50 -0600 | Rating Details | |
| 2024-12-04 16:43:34 -0600 | Rating Details | |
| 2024-12-04 16:26:02 -0600 | Rating Details | |
| 2024-12-04 16:17:36 -0600 | Rating Details | |
| 2024-12-04 15:46:08 -0600 | Rating Details | |
| 2024-12-04 15:00:14 -0600 | Rating Details | |
| 2024-12-04 14:52:50 -0600 | Rating Details | |
| 2024-12-04 14:51:11 -0600 | Rating Details | |
| 2024-12-04 14:26:45 -0600 | Rating Details | |
| 2024-12-04 14:01:13 -0600 | Rating Details | |
| 2024-12-04 13:57:02 -0600 | Rating Details | |
| 2024-12-04 13:27:47 -0600 | Rating Details | |
| 2024-12-04 13:26:41 -0600 | Rating Details | |
| 2024-12-04 13:15:42 -0600 | Rating Details | |
| 2024-12-04 12:53:43 -0600 | Rating Details | |
| 2024-12-06 12:52:49 -0600 | Rating Details | |
| 2024-12-06 03:35:34 -0600 | Rating Details | |
| 2024-12-06 01:09:14 -0600 | Rating Details | |
| 2024-12-05 20:50:38 -0600 | Rating Details | |
| 2024-12-05 19:35:37 -0600 | Rating Details | |
| 2024-12-05 16:58:33 -0600 | Rating Details | |
| 2024-12-05 15:08:40 -0600 | Rating Details | |
| 2024-12-05 14:07:44 -0600 | Rating Details | |
| 2024-12-05 13:46:38 -0600 | Rating Details | |
| 2024-12-05 10:30:44 -0600 | Rating Details | |
| 2024-12-05 08:48:36 -0600 | Rating Details | |
| 2024-12-05 08:37:15 -0600 | Rating Details | |
| 2024-12-05 08:26:16 -0600 | Rating Details | |
| 2024-12-05 08:18:54 -0600 | Rating Details | |
| 2024-12-05 08:12:13 -0600 | Rating Details | |
| 2024-12-05 05:40:56 -0600 | Rating Details | |
| 2024-12-05 05:16:03 -0600 | Rating Details | |
| 2024-12-05 05:03:39 -0600 | Rating Details | |
| 2024-12-05 04:02:01 -0600 | Rating Details | |
| 2024-12-05 02:18:13 -0600 | Rating Details | |
| 2024-12-05 01:15:47 -0600 | Rating Details | |
| 2024-12-05 01:04:44 -0600 | Rating Details | |
| 2024-12-04 23:42:56 -0600 | Rating Details | |
| 2024-12-04 23:32:04 -0600 | Rating Details | |
| 2024-12-04 22:21:36 -0600 | Rating Details | |
| 2024-12-04 22:16:03 -0600 | Rating Details | |
| 2024-12-04 21:52:15 -0600 | Rating Details | |
| 2024-12-04 21:18:31 -0600 | Rating Details | |
| 2024-12-04 20:02:49 -0600 | Rating Details | |
| 2024-12-04 19:34:35 -0600 | Rating Details | |
| 2024-12-04 19:26:54 -0600 | Rating Details | |
| 2024-12-08 21:49:33 -0600 | Rating Details | |
| 2024-12-07 22:40:34 -0600 | Rating Details | |
| 2024-12-05 20:44:11 -0600 | Rating Details | |
| 2024-12-05 19:48:42 -0600 | Rating Details | |
| 2024-12-05 17:05:02 -0600 | Rating Details | |
| 2024-12-05 14:15:27 -0600 | Rating Details | |
| 2024-12-05 11:49:34 -0600 | Rating Details | |
| 2024-12-05 09:35:09 -0600 | Rating Details | |
| 2024-12-05 06:52:40 -0600 | Rating Details | |
| 2024-12-05 06:37:15 -0600 | Rating Details | |
| 2024-12-05 04:22:17 -0600 | Rating Details | |
| 2024-12-05 00:34:29 -0600 | Rating Details | |
| 2024-12-05 00:27:46 -0600 | Rating Details | |
| 2024-12-04 23:59:33 -0600 | Rating Details | |
| 2024-12-04 23:50:58 -0600 | Rating Details | |
| 2024-12-04 22:33:42 -0600 | Rating Details | |
| 2024-12-04 21:09:53 -0600 | Rating Details | |
| 2024-12-04 20:06:42 -0600 | Rating Details | |
| 2024-12-04 17:52:27 -0600 | Rating Details | |
| 2024-12-04 16:48:53 -0600 | Rating Details | |
| 2024-12-04 16:31:50 -0600 | Rating Details | |
| 2024-12-04 15:29:03 -0600 | Rating Details | |
| 2024-12-04 15:20:21 -0600 | Rating Details | |
| 2024-12-04 15:09:13 -0600 | Rating Details | |
| 2024-12-04 14:38:13 -0600 | Rating Details | |
| 2024-12-04 13:12:34 -0600 | Rating Details | |
| 2024-12-04 12:57:34 -0600 | Rating Details | |
| 2024-12-04 12:57:03 -0600 | Rating Details | |
| 2024-12-13 20:22:57 -0600 | Rating Details |